Press Release
Find the latest news, announcements, and official updates from iSono Health, including product launches, partnerships, and company developments.
NIH SEED Sponsors iSono Health to Present at The MedTech Conference 2026
Selected by NIH SEED and the NCI SBIR Development Center, iSono Health joined a select group of NIH-sponsored companies presenting at The MedTech Conference 2026 in Boston, showcasing ATUSA™ and its vision for more accessible breast imaging.
Read the full article here
NVIDIA Healthcare Highlights iSono Health Among AI Innovators Advancing Breast Cancer Care
NVIDIA Healthcare featured iSono Health among NVIDIA for Startups partners using AI to advance breast cancer care, highlighting ATUSA™ and its automated 3D breast ultrasound technology.
Read the full article here
iSono Health Unveils ATUSA™: The World’s First Wearable, Automated, Portable, FDA-Cleared Breast Ultrasound Platform
Backed by $14.7M in Venture and SBIR Funding, iSono Health is opening its Series A at the Next Horizon Summit during JPMorgan Healthcare Week to Pursue a Multi-Billion-Dollar Opportunity in Breast Imaging
Read the full article here
iSono Health Launches Wearable AI-Powered 3D Breast Ultrasound Platform
iSono Health has stated that it has made a commercial release of ATUSA, an FDA-cleared wearable. This is a completely automated 3D quantitative breast ultrasound system, which is aimed at redefining the provision of breast imaging in routine clinical practices.
Read the full article here
Breast ultrasound technology developer iSono Health has launched its wearable, portable 3D breast ultrasound system, ATUSA.
Read the full article here
iSono Health announced it has commercially launched ATUSA, an FDA-cleared, wearable, automated 3D quantitative breast ultrasound platform that the company is positioning as a way to bring high-quality breast imaging into everyday clinics without relying on scarce sonographers or expensive traditional ultrasound systems.
Read the full article here
This week iSono Health—a company that specializes in developing solutions catered to women’s health—announced the commercial launch of its wearable breast ultrasound system.
Read the full article here
iSono Health has officially launched its FDA-cleared ATUSA™ platform, a wearable and automated 3D breast ultrasound system designed to make high-quality breast imaging more accessible and cost-effective. The platform’s commercial debut comes as the company opens its Series A financing round, marking a new growth phase focused on scaling deployments and advancing its AI-driven imaging roadmap.
Read the full article here
In a move that could redefine the landscape of women’s preventative health, medical technology pioneer iSono Health announced the commercial launch of ATUSA, the world’s first FDA-cleared, wearable, and automated 3D breast ultrasound platform.
Read the full article here
iSono Health’s commercial launch of ATUSA, an FDA-cleared, wearable, and automated 3D quantitative breast ultrasound platform, is designed to bring high-quality imaging into everyday clinics.
Read the full article here
Medical technology firm iSono Health has initiated the commercial launch of ATUSA™, the world’s first FDA-cleared wearable and automated 3D breast ultrasound platform. The move signals a potential paradigm shift in women’s healthcare, aiming to bring high-quality, accessible imaging out of specialized radiology suites and into local point-of-care clinics.
Read the full article here
PRESS CONTACT:
atusa@isonohealth.com
538 Oakmead Parkway, Sunnyvale, CA 94085 © 2014–2026 All rights reserved FCOI Policy